Diabetes: Medical Treatments

(asked on 7th June 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of Tirzepatide as a treatment for type two diabetes.


Answered by
Edward Argar Portrait
Edward Argar
Minister of State (Ministry of Justice)
This question was answered on 16th June 2022

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based recommendations for the National Health Service on whether licenced medicines represent a clinically and cost-effective use of resources. NICE is currently appraising Tirzepatide for the treatment of type 2 diabetes through its technology appraisal programme and expects to publish final guidance in April 2023.

Reticulating Splines